Hence, the transcriptional interplay among NFAT, TOX, and NR4A protein families influences T-cell exhaustion and inhibition of these factors that promote T-cell exhaustion could have a role in improving effector functions in cancer immunotherapy. This evidence concerns the gene TOX and cancer.